Furthermore, the study reported that patients with an age ≥18 months had higher tumor expression of TAM-related genes including CD14, CD16, CD33, FCGR3, Il-10, and IL6R compared to that of patients with age ≤ 18 months; and age is known to be a prognostic factor and used to guide risk classification (25). Here, IL10 is linked to neoplasm.